SlideShare a Scribd company logo
ARDS & VAP
Dr.Taniful haque
Resident
Rajshahi medical college hospital,Rajshahi.
Acute Respiratory Distress Syndrome (ARDS)
ARDS
• Acute respiratory distress syndrome is sudden and progressive
form of acute respiratory failure characterized by severe dyspnea,
hypoxemia & defuse pulmonary infiltrates.
• The syndrome was first described in 1967, and has been referred
to by several terms, including shock lung, traumatic capillary leak
syndrome, and adult hyaline membrane disease.
Berlin definition of ARDS
• Onset within 1 week
• Bilateral opacities on chest X-ray
• Respiratory failure not fully explained by cardiac failure or fluid
overload
• Impaired oxygenation
Pathophysiology
• Inflammation occurs throughout the lungs, affecting both endothelial
and epithelial surfaces.
• Activated neutrophils are sequestered into the lungs and capillary
permeability is increased, with damage to type I and II alveolar cells.
• This results in exudation and accumulation of proteinrich cellular fluid
within alveoli and the formation of characteristic ‘hyaline membranes’.
• Local release of cytokines and chemokines by activated macrophages
and neutrophils results in progressive recruitment of inflammatory cells.
• Secondary effects include loss of surfactant and impaired surfactant
production.
Stages
• Exudative stage
• Proliferative stage
• Fibrotic stage
Exudative Stage (0-6 Days)
• Accumulation of excessive fluid in the lungs due to exudation
(leaking of fluids) and acute injury.
• Hypoxemia is usually most severe during this phase of acute
injury, as is injury to the endothelium (lining membrane) and
epithelium (surface layer of cells).
Some individuals quickly recover from this first stage; many others
progress after about a week into the second stage.
Proliferative Stage (7-10 Days)
• Connective tissue and other structural elements in the lungs
proliferate in response to the initial injury, including development
of fibroblasts.
• The terms "stiff lung" and "shock lung" frequently used to
characterize this stage.
• Abnormally enlarged air spaces and fibrotic tissue (scarring) are
increasingly apparent.
Fibrotic Stage (>10-14 Days)
• Inflammation resolves.
• Oxygenation improves and extubation becomes possible.
• Lung function may continue to improve for as long as 6 to 12
months after onset of respiratory failure, depending on the
precipitating condition and severity of the initial injury.
• Varying levels of pulmonary fibrotic changes are possible.
Predisposing Factors
• Inhalation (direct)
• Aspiration of gastric contents • Toxic gases/burn injury •
Pneumonia • Blunt chest trauma • Near-drowning
• Blood-borne (indirect)
• Sepsis • Necrotic tissue (particularly bowel) • Multiple trauma
•Pancreatitis • Cardiopulmonary bypass • Drugs (heroin,
barbiturates, thiazides) • Severe burns • Major transfusion
reaction • Anaphylaxis • Fat embolism • Carcinomatosis •
Obstetric crises (amniotic fluid embolus, eclampsia)
Early Signs & Symptoms
• Dyspnea
• Restlessness
• Confusion
• Drowsiness
• Extreme tiredness
• Low blood pressure
• If pneumonia causing ARDS: Cough, Fever etc.
Late Signs & Symptoms
• Severe difficulty in breathing (i.e. labored, rapid breathing.)
Shortness of breath
Tachycardia
Thick frothy sputum
Metabolic acidosis
Cyanosis
Abnormal breath sounds (i.e. crackle, wheeze.)
Decreased PaCo2 with respiratory alkalosis
Diagnosis
• History
• Examination: cyanosis, wheeze, crackles, tachycardia etc.
• Investigation:
• ABG
• CBC
• Chest X-ray
• Sputum for C/S
• Chest CT scan
• All other routine investigations
Management
• No specific therapy for ARDS
• Patients should be hospitalized and may require ICU support
• Supportive measure includes O2 supplementation & mechanical
ventilation
• Position strategy includes porne & lateral rotation
• Adequate fluid management
Oxygen Therapy
• Goal of O2 therapy is to correct hypoxemia (SpO2= ≥92-94%)
• Oxygen can be administered by-
• Nasal cannula: upto 6L/min
• Simple facemask: upto 10L/min
• Venturi facemask: upto 15L/min
• Partial rebreathing facemask: upto 15L/min
• Non-rebreather facemask: upto 15L/min
• High flow nasal cannula: upto 70L/min
• Mechanical ventilation
Medications
• Antibiotics
• Steroids
• Inhaled bronchodilators
• Diuretics
• Ionotropic & chronotropic support
Prone Positioning
• About 2/3rd of patients with ARDS improve their oxygenation after
being placed in a prone position
• The mechanism includes:
• Increased FRC
• Change in regional diaphragmatic motion
• Perfusion redistribution
• Improved clearance of secretions
Ventilator Associated Pneumonia (VAP)
VAP
• Ventilator Associated Pneumonia (VAP) is a type of hospital
acquired pneumonia that develop more than 48 to 72 hours after
endotracheal intubation.
Know The Enemy
• Endotracheal intubation increases risk of developing pneumonia by
6 to 21 fold
• Accounts fot 90% of infections in mechanically ventilated patients
Why in ICU patients?
• Sickest patients (multiple diseases, immunocompromised,
multi-organ failure, septic and trauma)
• Less movements
• Malnourished
• Diabetic & heart failure
Types
• Early onset VAP:
• Less than 4 days after intubation
• Responsible pathogens are usually susceptible to antibiotics
• Late onset VAP:
• Greater than 4 days after intubation
• Responsible pathogens are usually resistant to antibiotics
Pathophysiology
• Bacteria enter the lower respiratory tract via following pathways-
• Inspiration of organisms from the oropharynx & GIT (most common cause)
• Direct inoculation
• Inhalation of bacteria
• Haematogenous spread
Pathogens
Early onset VAP
• Streptococcus pneumoniae
• Staphylococcus aureus
• Hemophilus influenzae
• Klebsiella pneumoniae
• Escherichia coli
• Proteus species
Late onset VAP
• Pseudomonas aeruginosa
• MRSA (Methicillin Resistant
Staphylococcus Aureus)
• VRE (Vancomycin Resistant
Enterococcus)
• Enterobacter species
Diagnosis
• Clinical:
• Fever
• Leukocytosis
• Purulent secretions, Bronchial breath sound
• Cough, Dyspnea,Tachypnea, reduced SpO2 etc.
• Microbiological: Culture & sensitivity
• Radiological:
• New and progressive pulmonary infiltrates
• Consolidation, opacity or cavitation
Treatment
• Treatment of VAP still remains a difficult and complex
undertaking.
• Clinical evidence suggests that early use of appropriate empiric
antibiotic therapy improves patient outcome in-
• Reduced mortality
• Reduced morbidity
• Reduced hospital stay
Prevention
• Hand washing before & after suctioning or touching
• Restriction of visitors
• Continuous removal of subglottic secretions
• HOB elevation (if not contraindicated)
• HME prevents bacterial colonization
Thank You All
l

More Related Content

Similar to ARDS & VAP.pptx

Respiratory distress in newborn
Respiratory distress in newbornRespiratory distress in newborn
Respiratory distress in newborn
Ibrahim Aminu
 
Chronic obstructive pulmonary disease 1
Chronic obstructive pulmonary disease 1Chronic obstructive pulmonary disease 1
Chronic obstructive pulmonary disease 1
Manju Mulamootll Abraham
 
Respiratory Distress in Newborns
Respiratory Distress in NewbornsRespiratory Distress in Newborns
Respiratory Distress in NewbornsThe Medical Post
 
ARDS Anaesthesia seminar 2023.pptx
ARDS Anaesthesia seminar 2023.pptxARDS Anaesthesia seminar 2023.pptx
ARDS Anaesthesia seminar 2023.pptx
drsandeepsinghjadon
 
acute respiratory distress syndrome.pptx
acute respiratory distress syndrome.pptxacute respiratory distress syndrome.pptx
acute respiratory distress syndrome.pptx
NanditaHalder3
 
COPD
COPDCOPD
Acute respiratory distress syndrome (ARDS)
Acute respiratory distress syndrome (ARDS)Acute respiratory distress syndrome (ARDS)
Acute respiratory distress syndrome (ARDS)
Sunil kumar
 
Pneumonia & bronchiolitis
Pneumonia & bronchiolitisPneumonia & bronchiolitis
Pneumonia & bronchiolitis
dhaval joshi
 
Ventilation and Diffusion.docx
Ventilation and Diffusion.docxVentilation and Diffusion.docx
Ventilation and Diffusion.docx
CENichols
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
rajendra gopal
 
COPD
COPDCOPD
6) respiratory failure.pptx
6) respiratory failure.pptx6) respiratory failure.pptx
6) respiratory failure.pptx
ssuser523204
 
Atelectasis
AtelectasisAtelectasis
Atelectasis
shristi shrestha
 
Pneumothorax : Cause and management
Pneumothorax : Cause and managementPneumothorax : Cause and management
Pneumothorax : Cause and management
DR SAURAV SUMAN
 
RESPIRATORY SYSTEM: INTRODUCTION, ATELECTASIS, ARDS
RESPIRATORY SYSTEM: INTRODUCTION, ATELECTASIS, ARDSRESPIRATORY SYSTEM: INTRODUCTION, ATELECTASIS, ARDS
RESPIRATORY SYSTEM: INTRODUCTION, ATELECTASIS, ARDS
Vijay Shankar
 
Acute respiratory distress syndrome
Acute respiratory distress syndromeAcute respiratory distress syndrome
Acute respiratory distress syndrome
Asraf Hussain
 
REVIEW OF COMMUNITY ACQUIRED PNEUMONIA..
REVIEW OF COMMUNITY ACQUIRED PNEUMONIA..REVIEW OF COMMUNITY ACQUIRED PNEUMONIA..
REVIEW OF COMMUNITY ACQUIRED PNEUMONIA..
Tayyaba Khalid
 
ARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptxARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptx
ShubhrimaKhan
 
pneumonia for C-1.pptx
pneumonia for C-1.pptxpneumonia for C-1.pptx
pneumonia for C-1.pptx
IbsaAli1
 

Similar to ARDS & VAP.pptx (20)

Respiratory distress in newborn
Respiratory distress in newbornRespiratory distress in newborn
Respiratory distress in newborn
 
Chronic obstructive pulmonary disease 1
Chronic obstructive pulmonary disease 1Chronic obstructive pulmonary disease 1
Chronic obstructive pulmonary disease 1
 
Respiratory Distress in Newborns
Respiratory Distress in NewbornsRespiratory Distress in Newborns
Respiratory Distress in Newborns
 
ARDS Anaesthesia seminar 2023.pptx
ARDS Anaesthesia seminar 2023.pptxARDS Anaesthesia seminar 2023.pptx
ARDS Anaesthesia seminar 2023.pptx
 
acute respiratory distress syndrome.pptx
acute respiratory distress syndrome.pptxacute respiratory distress syndrome.pptx
acute respiratory distress syndrome.pptx
 
COPD
COPDCOPD
COPD
 
Acute respiratory distress syndrome (ARDS)
Acute respiratory distress syndrome (ARDS)Acute respiratory distress syndrome (ARDS)
Acute respiratory distress syndrome (ARDS)
 
Pneumonia & bronchiolitis
Pneumonia & bronchiolitisPneumonia & bronchiolitis
Pneumonia & bronchiolitis
 
Ventilation and Diffusion.docx
Ventilation and Diffusion.docxVentilation and Diffusion.docx
Ventilation and Diffusion.docx
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
 
COPD
COPDCOPD
COPD
 
6) respiratory failure.pptx
6) respiratory failure.pptx6) respiratory failure.pptx
6) respiratory failure.pptx
 
Pul edema
Pul edemaPul edema
Pul edema
 
Atelectasis
AtelectasisAtelectasis
Atelectasis
 
Pneumothorax : Cause and management
Pneumothorax : Cause and managementPneumothorax : Cause and management
Pneumothorax : Cause and management
 
RESPIRATORY SYSTEM: INTRODUCTION, ATELECTASIS, ARDS
RESPIRATORY SYSTEM: INTRODUCTION, ATELECTASIS, ARDSRESPIRATORY SYSTEM: INTRODUCTION, ATELECTASIS, ARDS
RESPIRATORY SYSTEM: INTRODUCTION, ATELECTASIS, ARDS
 
Acute respiratory distress syndrome
Acute respiratory distress syndromeAcute respiratory distress syndrome
Acute respiratory distress syndrome
 
REVIEW OF COMMUNITY ACQUIRED PNEUMONIA..
REVIEW OF COMMUNITY ACQUIRED PNEUMONIA..REVIEW OF COMMUNITY ACQUIRED PNEUMONIA..
REVIEW OF COMMUNITY ACQUIRED PNEUMONIA..
 
ARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptxARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptx
 
pneumonia for C-1.pptx
pneumonia for C-1.pptxpneumonia for C-1.pptx
pneumonia for C-1.pptx
 

Recently uploaded

Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 

Recently uploaded (20)

Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 

ARDS & VAP.pptx

  • 1. ARDS & VAP Dr.Taniful haque Resident Rajshahi medical college hospital,Rajshahi.
  • 2. Acute Respiratory Distress Syndrome (ARDS)
  • 3. ARDS • Acute respiratory distress syndrome is sudden and progressive form of acute respiratory failure characterized by severe dyspnea, hypoxemia & defuse pulmonary infiltrates. • The syndrome was first described in 1967, and has been referred to by several terms, including shock lung, traumatic capillary leak syndrome, and adult hyaline membrane disease.
  • 4. Berlin definition of ARDS • Onset within 1 week • Bilateral opacities on chest X-ray • Respiratory failure not fully explained by cardiac failure or fluid overload • Impaired oxygenation
  • 5.
  • 6. Pathophysiology • Inflammation occurs throughout the lungs, affecting both endothelial and epithelial surfaces. • Activated neutrophils are sequestered into the lungs and capillary permeability is increased, with damage to type I and II alveolar cells. • This results in exudation and accumulation of proteinrich cellular fluid within alveoli and the formation of characteristic ‘hyaline membranes’. • Local release of cytokines and chemokines by activated macrophages and neutrophils results in progressive recruitment of inflammatory cells. • Secondary effects include loss of surfactant and impaired surfactant production.
  • 7.
  • 8. Stages • Exudative stage • Proliferative stage • Fibrotic stage
  • 9. Exudative Stage (0-6 Days) • Accumulation of excessive fluid in the lungs due to exudation (leaking of fluids) and acute injury. • Hypoxemia is usually most severe during this phase of acute injury, as is injury to the endothelium (lining membrane) and epithelium (surface layer of cells). Some individuals quickly recover from this first stage; many others progress after about a week into the second stage.
  • 10. Proliferative Stage (7-10 Days) • Connective tissue and other structural elements in the lungs proliferate in response to the initial injury, including development of fibroblasts. • The terms "stiff lung" and "shock lung" frequently used to characterize this stage. • Abnormally enlarged air spaces and fibrotic tissue (scarring) are increasingly apparent.
  • 11. Fibrotic Stage (>10-14 Days) • Inflammation resolves. • Oxygenation improves and extubation becomes possible. • Lung function may continue to improve for as long as 6 to 12 months after onset of respiratory failure, depending on the precipitating condition and severity of the initial injury. • Varying levels of pulmonary fibrotic changes are possible.
  • 12. Predisposing Factors • Inhalation (direct) • Aspiration of gastric contents • Toxic gases/burn injury • Pneumonia • Blunt chest trauma • Near-drowning • Blood-borne (indirect) • Sepsis • Necrotic tissue (particularly bowel) • Multiple trauma •Pancreatitis • Cardiopulmonary bypass • Drugs (heroin, barbiturates, thiazides) • Severe burns • Major transfusion reaction • Anaphylaxis • Fat embolism • Carcinomatosis • Obstetric crises (amniotic fluid embolus, eclampsia)
  • 13. Early Signs & Symptoms • Dyspnea • Restlessness • Confusion • Drowsiness • Extreme tiredness • Low blood pressure • If pneumonia causing ARDS: Cough, Fever etc.
  • 14. Late Signs & Symptoms • Severe difficulty in breathing (i.e. labored, rapid breathing.) Shortness of breath Tachycardia Thick frothy sputum Metabolic acidosis Cyanosis Abnormal breath sounds (i.e. crackle, wheeze.) Decreased PaCo2 with respiratory alkalosis
  • 15. Diagnosis • History • Examination: cyanosis, wheeze, crackles, tachycardia etc. • Investigation: • ABG • CBC • Chest X-ray • Sputum for C/S • Chest CT scan • All other routine investigations
  • 16.
  • 17. Management • No specific therapy for ARDS • Patients should be hospitalized and may require ICU support • Supportive measure includes O2 supplementation & mechanical ventilation • Position strategy includes porne & lateral rotation • Adequate fluid management
  • 18. Oxygen Therapy • Goal of O2 therapy is to correct hypoxemia (SpO2= ≥92-94%) • Oxygen can be administered by- • Nasal cannula: upto 6L/min • Simple facemask: upto 10L/min • Venturi facemask: upto 15L/min • Partial rebreathing facemask: upto 15L/min • Non-rebreather facemask: upto 15L/min • High flow nasal cannula: upto 70L/min • Mechanical ventilation
  • 19.
  • 20. Medications • Antibiotics • Steroids • Inhaled bronchodilators • Diuretics • Ionotropic & chronotropic support
  • 21. Prone Positioning • About 2/3rd of patients with ARDS improve their oxygenation after being placed in a prone position • The mechanism includes: • Increased FRC • Change in regional diaphragmatic motion • Perfusion redistribution • Improved clearance of secretions
  • 23. VAP • Ventilator Associated Pneumonia (VAP) is a type of hospital acquired pneumonia that develop more than 48 to 72 hours after endotracheal intubation.
  • 24. Know The Enemy • Endotracheal intubation increases risk of developing pneumonia by 6 to 21 fold • Accounts fot 90% of infections in mechanically ventilated patients
  • 25. Why in ICU patients? • Sickest patients (multiple diseases, immunocompromised, multi-organ failure, septic and trauma) • Less movements • Malnourished • Diabetic & heart failure
  • 26. Types • Early onset VAP: • Less than 4 days after intubation • Responsible pathogens are usually susceptible to antibiotics • Late onset VAP: • Greater than 4 days after intubation • Responsible pathogens are usually resistant to antibiotics
  • 27. Pathophysiology • Bacteria enter the lower respiratory tract via following pathways- • Inspiration of organisms from the oropharynx & GIT (most common cause) • Direct inoculation • Inhalation of bacteria • Haematogenous spread
  • 28. Pathogens Early onset VAP • Streptococcus pneumoniae • Staphylococcus aureus • Hemophilus influenzae • Klebsiella pneumoniae • Escherichia coli • Proteus species Late onset VAP • Pseudomonas aeruginosa • MRSA (Methicillin Resistant Staphylococcus Aureus) • VRE (Vancomycin Resistant Enterococcus) • Enterobacter species
  • 29. Diagnosis • Clinical: • Fever • Leukocytosis • Purulent secretions, Bronchial breath sound • Cough, Dyspnea,Tachypnea, reduced SpO2 etc. • Microbiological: Culture & sensitivity • Radiological: • New and progressive pulmonary infiltrates • Consolidation, opacity or cavitation
  • 30. Treatment • Treatment of VAP still remains a difficult and complex undertaking. • Clinical evidence suggests that early use of appropriate empiric antibiotic therapy improves patient outcome in- • Reduced mortality • Reduced morbidity • Reduced hospital stay
  • 31. Prevention • Hand washing before & after suctioning or touching • Restriction of visitors • Continuous removal of subglottic secretions • HOB elevation (if not contraindicated) • HME prevents bacterial colonization